We are international
Donate
TEXT SIZE   


Myeloma Minute
October 22, 2015
10.22.15
October 22, 2015
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: What does it mean to be MRD-negative if you have high-risk 17p-myeloma?


Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

 

Saturday, November 14, 2015
Regional Community Workshop

Washington D.C.

Thursday, November 19, 2015
Living Well with Myeloma

"Myeloma 101: Updates on Treatment & Pain Management"

 

Saturday, November 21, 2015
Regional Community Workshop

Chicago, Illinois

 

Friday, December 4, 2015
IMF Satellite Symposium

Orlando, Florida/Live Stream

 

    

x

Is There Value or Risk in New Guidance on Myeloma Treatment?

In his blog this week, IMF Chairman Dr. Brian Durie comments on the myeloma treatment guidance issued last week by the National Comprehensive Cancer Network (NCCN). The NCCN says its “evidence blocks” approach will provide a tool to educate providers and patients about “efficacy, safety, and affordability” of treatments. It is just one of several recent efforts to evaluate and recommend specific cancer treatment paths. Dr. Durie weighs in on the relative merits and drawbacks of these efforts. To read, click HERE.

 

x

Stellar Lineup of Myeloma Experts Featured at IMF Satellite Symposium--Join Us in Person or Watch via Live Stream



 

On Friday, Dec. 4, preceding the 57th Annual Meeting of the American Society of Hematology (ASH) in Orlando, FL, the IMF will present Global Advances in Myeloma: Providing Best Options for Treatment in 2015. Led by IMF Chairman and symposium Program Director Dr. Brian Durie, this provocative program includes “point and counterpoint” presentations and interactive case discussions to provide varied perspectives on new data, guideline changes, and expert recommendations in myeloma. Panelists: Shaji Kumar, MD; Philippe Moreau, MD; Bruno Paiva, PhD; Antonio Palumbo, MD; and Jesús San Miguel, MD. For more information and to register to attend, click HERE.

x

Myeloma Patient Registered to Run His 90th Marathon with Cancer



 

Don Wright didn’t let his 2003 myeloma diagnosis stop him in tracks. This weekend, Don is registered to run his 90th marathon with myeloma in Washington, D.C. The 74-year old says he’s managed his cancer for seven of the last twelve years with oral cancer therapies, but knows “multiple myeloma cannot be cured, so I am counting on continuing progress, research and access to the latest treatments to provide the next remission and the remission after that.” To read the full story, click HERE.

x

Register for November Veterans Against Myeloma Webinar Now


 

The IMF’s “Veterans Against Myeloma Teleconference Series” will host a free webinar Thursday, Nov. 12 at 7 PM ET, 4 PM PT titled Multiple Myeloma and VA Benefits: Strategies for Veterans to Maximize Access to VA Support. This 60-minute webinar will feature speaker Raymond Gustavson, award-winning novelist and retired Rating Specialist on the Department of Veterans Affairs (VA) Appeals Team. The webinar will focus on providing education to veterans about how they can better seek out benefits from the US Dept. of Veterans Affairs. To register for the webinar please click HERE.

 


Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.

 


 related articles